Alpha Tau Medical Ltd.
DRTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $377,722 | $250,703 | $176,832 | $217,286 |
| - Cash | $3,329 | $11,703 | $5,019 | $13,724 |
| + Debt | $13,502 | $13,314 | $12,293 | $12,536 |
| Enterprise Value | $387,895 | $252,314 | $184,106 | $216,098 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10,455 | -$9,177 | -$9,308 | -$5,398 |
| % Margin | – | – | – | – |
| Net Income | -$11,686 | -$10,114 | -$8,691 | -$9,476 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.14 | -0.13 | -0.12 | -0.14 |
| % Growth | -7.7% | -8.3% | 14.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |